Safety and tolerability of chikungunya virus-like particle vaccine in healthy adults: a phase 1 dose-escalation trial-Reference-Cited by-同舟云学术

Safety and tolerability of chikungunya virus-like particle vaccine in healthy adults: a phase 1 dose-escalation trial

Published:2014-12 Issue:9959 Volume:384 Page:2046-2052
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Chang Lee-Jah,Dowd Kimberly A,Mendoza Floreliz H,Saunders Jamie G,Sitar Sandra,Plummer Sarah H,Yamshchikov Galina,Sarwar Uzma N,Hu Zonghui,Enama Mary E,Bailer Robert T,Koup Richard A,Schwartz Richard M,Akahata Wataru,Nabel Gary J,Mascola John R,Pierson Theodore C,Graham Barney S,Ledgerwood Julie E

Publisher

Elsevier BV

Subject

General Medicine

Reference39 articles.

1. A virus-like particle vaccine for epidemic chikungunya virus protects nonhuman primates against infection;Akahata;Nat Med,2010

2. Genetic divergence of chikungunya viruses in India (1963–2006) with special reference to the 2005–2006 explosive epidemic;Arankalle;J Gen Virol,2007

3. Changing patterns of chikungunya virus: re-emergence of a zoonotic arbovirus;Powers;J Gen Virol,2007

4. Present and future arboviral threats;Weaver;Antiviral Res,2010

5. Chikungunya: a potentially emerging epidemic?;Thiboutot;PLoS Negl Trop Dis,2010

Cited by 204 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunogenicity and Safety of Chikungunya Vaccines: A Systematic Review and Meta-Analysis;Vaccines;2024-08-27

2. Chikungunya virus vaccine: a decade of progress solving epidemiological dilemma, emerging concepts, and immunological interventions;Frontiers in Microbiology;2024-07-22

3. Identifying Key Drivers of Efficient B Cell Responses: On the Role of T Help, Antigen-Organization, and Toll-like Receptor Stimulation for Generating a Neutralizing Anti-Dengue Virus Response;Vaccines;2024-06-14

4. Use of Transient Transfection for cGMP Manufacturing of eOD-GT8 60mer, a Self-Assembling Nanoparticle Germline-Targeting HIV-1 Vaccine Candidate;Pharmaceutics;2024-05-30

5. Enhanced attenuation of chikungunya vaccines expressing antiviral cytokines;npj Vaccines;2024-03-12